---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-104769"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T07:38:59.741622+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics receives Nasdaq delisting notice for bid price below $1.00 for 30 consecutive days

## Summary
- Received Nasdaq notice on Sept 27, 2023 for non-compliance with minimum bid price requirement (Rule 5550(a)(2)).
- Common stock closed below $1.00 per share for 30 consecutive business days.
- Company has 180-day grace period through March 25, 2024 to regain compliance by closing at $1.00+ for 10+ consecutive days.
- If not compliant by March 25, 2024, may seek second 180-day period if it meets initial listing criteria and intends to reverse split.
- Company will monitor bid price and consider options; no assurance of maintaining listing.

## SEC filing metadata
- accession: 0001104659-23-104769
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923104769/0001104659-23-104769-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923104769/tm2327174d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-104769
- JSON: https://secwatch.observer/filing/0001104659-23-104769.json
- Plain text: https://secwatch.observer/filing/0001104659-23-104769.txt

## Key facts
- Listing & Compliance Notices
  AVENUE THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: September 27, 2023, Avenue Therapeutics, Inc. (the “ Company ”) received a letter from the Staff of the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that the bid price of the Company’s common stock (“ Common Stock ”) had closed below $1.00 per share for 30 consecutive business days, and that, therefore, the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “ Minimum-Bid Price Requirement ”), which sets forth the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq’s notice has no i
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465923104769/0001104659-23-104769-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.